RMTG unit Cellgenic adds two ISO 7 clean rooms at Cancún lab
RMTG•Shift toward owned infrastructure
Investment shifts Cellgenic toward owned infrastructure, aiming to cut supply constraints as it scales recurring supply revenue.
Expanded footprint in Cancún aligns Cellgenic’s manufacturing base with Cellular Hope Institute’s clinical presence in the city.
Cellgenic expands Cancún lab capacity
Cellgenic, a unit of Regenerative Medical Technology Group, expanded its Cancún lab with two ISO 7 clean rooms.
Added capacity targets higher manufacturing output, faster product development, stronger quality systems for a growing international portfolio.
